Searched for
SUN PHARMACEUTICAL REVENUE GROWTH
Domestic formulations, chronic therapies to drive Pharma Q1; US generics remain dragThe healthcare sector anticipates strong growth in domestic formulations and emerging markets. Companies with less US generics dependence w...- Explained: What Donald Trump's up to 200% pharma tariffs mean for Indian investorsDonald Trump's announcement of tariffs of up to 200% on pharmaceutical imports triggered a selloff in Indian pharma stocks. However, analys...
- Indian pharma firms may yet survive Trump's 200% tariff bombshellDonald Trump's proposed up to 200% tariff on generic drug imports has raised concerns for Indian pharma companies, but industry experts say...
- 200% Trump tariff shock? India’s cheap pills may still beat US rivalsUS President Donald Trump's proposed tariffs of up to 200% on imported generic medicines could put pressure on India's pharmaceutical expor...
- Trump’s 100% generic drug duty threatens US low-cost supplyPresident Donald Trump has given generic drugmakers two years to shift manufacturing to the US or face 100% import tariffs from August 2028...
- Trump's Generic Drug Tariffs Explained: What it means for Indian pharma before the 200% stormTrump's generic drug tariffs plan provides Indian drugmakers a two-year duty-free window. This allows companies time to reassess manufactur...
- Trump announces new generic drugs tariff plan: No tariffs for 2 years, then 100%, and then 200%For Indian exporters, the two-year tariff-free period offers additional time to reassess supply chains and investment plans. While the imme...
- Sun Pharma, Cipla & other pharma stocks shed over 2% as Trump announces up to 200% tariffs on generic drugs from 2028Pharma stocks, including Sun Pharma, Cipla, Lupin and Dr Reddy's, fell up to 2.5% after US President Donald Trump announced a phased tariff...
- IT growth under pressure amid delayed deal ramp-upsRatings agency Crisil last week forecasted the $315-billion industry to grow just 1-3% on a constant currency basis in FY27 and 2-4% in FY2...
- What happens on July 22 when the Sun enters Leo? Astrologers say Leo, Aries, Sagittarius, Libra, and Gemini may experience a surge of confidence and creative energyEvery year around July 22, the Sun appears to move into the zodiac sign of Leo, marking the beginning of what astrologers call Leo season. ...
- Sun Enters Leo on July 22, 2026: What This Powerful Transit Means for Every Zodiac SignThe Sun enters Leo on July 22, 2026, ushering in a period of enhanced confidence and leadership. This powerful transit will influence caree...
- Alembic Pharma partner NATCO gets USFDA tentative nod for generic Olaparib tablets; US market size at USD 1.4 bnAlembic Pharmaceuticals and NATCO Pharma received tentative USFDA approval for generic Olaparib tablets. This approval is for a cancer drug...
- Subscription, digital Ad sales boost JioStar showJioStar's Ebitda from operations increased thirty-one percent year-on-year. Higher subscription revenue and digital entertainment advertisi...
- Warburg Pincus buys Mumbai’s pharma company Integrace in Rs 1,200 crore dealIn a landmark transaction, Warburg Pincus, a prominent US private equity firm, has purchased Integrace Private Limited for ₹1,200 crore. Wi...
- Sun Pharma among 5 stocks that hit 52-week highs & rallied up to 20% in a monthThe Sensex gained 130 points on Wednesday, while five BSE 200 stocks—Paytm, Divi's Laboratories, Torrent Pharmaceuticals, Sun Pharmaceutica...
- Sun in Cancer 2026: Biggest Career, Love and Money Predictions for Every Zodiac SignSun Transit 2026 occurs on 16 July 2026, when the Sun enters Cancer (Karka Rashi). This important Sun Transit in Cancer shifts attention to...
- Pushya Nakshatra: Sun Transit in Pushya Nakshatra Brings Luck to Cancer, Taurus, Virgo, Libra & Aquarius From July 20, 2026On 20th July 2026, the Sun, the planet of authority, confidence, leadership, and vitality, will enter Pushya Nakshatra. Ruled by Saturn and...
- Sun Pharma gets SAHPRA approval for generic semaglutide injection in South Africa for type 2 diabetesSouth Africa's regulator approved Sun Pharma's generic semaglutide injection for diabetes. This approval allows marketing to supplement die...
- Bonus issue alert! Last day to buy this microcap pharma stock that rallied 200% in one yearFredun Pharmaceuticals has fixed July 16 as the record date for its 2:1 bonus issue, making today the last day to buy the stock to qualify....
- Pharma companies' Q1 margins likely to decline despite revenue growth: Goldman SachsIndian pharmaceutical firms anticipate revenue increases in the first quarter of fiscal year twenty twenty six twenty seven. Profitability ...
Load More
